Ouranidis, A.; Gkampelis, N.; Vardaka, E.; Karagianni, A.; Tsiptsios, D.; Nikolakakis, I.; Kachrimanis, K.
Overcoming the Solubility Barrier of Ibuprofen by the Rational Process Design of a Nanocrystal Formulation. Pharmaceutics 2020, 12, 969.
https://doi.org/10.3390/pharmaceutics12100969
AMA Style
Ouranidis A, Gkampelis N, Vardaka E, Karagianni A, Tsiptsios D, Nikolakakis I, Kachrimanis K.
Overcoming the Solubility Barrier of Ibuprofen by the Rational Process Design of a Nanocrystal Formulation. Pharmaceutics. 2020; 12(10):969.
https://doi.org/10.3390/pharmaceutics12100969
Chicago/Turabian Style
Ouranidis, Andreas, Nikos Gkampelis, Elisavet Vardaka, Anna Karagianni, Dimitrios Tsiptsios, Ioannis Nikolakakis, and Kyriakos Kachrimanis.
2020. "Overcoming the Solubility Barrier of Ibuprofen by the Rational Process Design of a Nanocrystal Formulation" Pharmaceutics 12, no. 10: 969.
https://doi.org/10.3390/pharmaceutics12100969
APA Style
Ouranidis, A., Gkampelis, N., Vardaka, E., Karagianni, A., Tsiptsios, D., Nikolakakis, I., & Kachrimanis, K.
(2020). Overcoming the Solubility Barrier of Ibuprofen by the Rational Process Design of a Nanocrystal Formulation. Pharmaceutics, 12(10), 969.
https://doi.org/10.3390/pharmaceutics12100969